Kuano
The startup combines quantum physics, artificial intelligence (AI) and medicinal chemistry in a unique approach to transforming the discovery of therapeutics focused on enzyme inhibition.
London, UKwww.kuano.ai ↗
Total raised
€3.3M
€3,256,412
Funding rounds
2
Investors
6
distinct backers
Active since
2021-07
latest 2023-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood36
base rate 44% for Seed
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-12 | Seed | €2.1M | ACF investors,Angel Investors,Ascension Ventures,Meltwind Advisory LLP,Mercia Ventures,o2h Ventures | View deal → |
| 2021-07-08 | Seed | €1.2M | ACF investors,o2h Ventures | View deal → |
Investors
6Related news
- UK biotech startup Kuano lands £1M for AI-driven drug discoveryuktech.news · 2021-07
- tech.eu